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Abstract
Background: Due to antibiotic treatment of humans and animals, the prevalence of bacterial resistances increases
worldwide. Especially in livestock farming, large quantities of faeces contaminated with antibiotics pose a risk of the
carryover of the active ingredient to the environment. Accordingly, the aim of the present study was the evaluation
of the benefit of different oral dosage forms (powder, pellets, granula) in pigs concerning the environmental pollution
of sulfadiazine. Two subtherapeutic dosages were evaluated in powder mixtures to gain information about their
potential to pollute the pig barn. Furthermore, a new group of pigs was kept in the stable after powder feeding
of another pig group to determine the possible absorption of environmentally distributed antibiotics.
Pigs were orally treated with three dosage forms. Simultaneously, sedimentation and airborne dust were collected and
plasma and urine levels were determined.
Results: All formulations result in comparable plasma and urine levels, but massive differences in environmental
pollution (powder > pellets, granula). Pigs housing in a contaminated barn exhibit traces of sulfadiazine in plasma
and urine.
Conclusion: Using pharmaceutical formulations like pellets or granula, the environmental pollution of sulfonamides
can significantly be diminished due to massive dust reduction during feeding.
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Background
To achieve an efficient treatment of animals and humans
suffering from bacterial disease, an adequate antibiotic
treatment is often required. A closer look into the anti-
bacterial treatment of animals in Europe demonstrates
that sulfonamides, tetracyclines and ß-lactam antibiotics
are the most frequently used antibacterial agents [1–3].
Sulfonamides can be used in the treatment against gram-
positive and gram-negative bacteria, as well as several
rickettsia and protozoa (Toxoplasma, Coccidia) [4]. Active
metabolites of sulfonamide excreted in urine or feces may
pollute the environment [5–9]. Contamination from
animal husbandry primarily affects soil and water, with
pig, poultry and cattle manure, slurry and liquid dung,
hospital waste water and sewage being the main sources
[8, 10, 11]. Moreover, it has been demonstrated that sul-
fonamides contaminate ground water in particular by sur-
face run off or sediment of shrimp ponds [12–15]. These
antibiotic residues in the environment deriving from the
antibiotic drug itself or its antibiotic metabolites pose the
risk of the development of bacterial resistance due to
subinhibitory concentrations (concentrations beyond the
minimal inhibitory concentration) [16]. The antibiotic
substance may be inhaled and swallowed. Furthermore,
it can contaminate the skin of individuals and thus gets
in contact with the normal skin flora, or it can orally be
incorporated into the body, due to the contamination
of food products. Tetracyclines and sulfonamides for
example have been found in agricultural crops after
* Correspondence: jessica.stahl@tiho-hannover.de
†Equal contributors
1Department of Pharmacology, Toxicology and Pharmacy, University of
Veterinary Medicine Hannover, Foundation, Buenteweg 17, 30559 Hannover,
Germany
Full list of author information is available at the end of the article
© 2016 Stahl et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Stahl et al. BMC Veterinary Research  (2016) 12:68 
DOI 10.1186/s12917-016-0688-6
distribution of antibiotic containing manure [17, 18].
Consequently, intestinal bacteria can be affected, as well.
Another risk is, that antibiotics in stable dust can be
distributed into the environment of the stable via emis-
sion [19–21].
Concerning the current problems of antibacterial re-
sistances in both human and veterinary medicine and the
associated problems of the inability of healing seriously
ill individuals, it is of high importance to reduce the
dissemination of antibacterial agents into the environ-
ment. Hamscher et al. (2003) demonstrated that antibiotic
residues can be determined in stable dust for a long time
[22]. Therefore, the present study was conducted to inves-
tigate the ability of different pharmaceutical formulations
of antibiotics (sulfonamides) in the treatment of pigs to
reduce environmental contaminations. Sulfonamide ap-
plication was performed via powder, pellets and granula
in order to test the absorption of the antibiotic agent in
the oral dosage forms with various firmnesses (powder <
pellets < granula). Environmental contamination was ex-
amined by collecting sedimentation dust in the stable and
aerosol. Furthermore, untreated pigs (sentinels) were
housed in a dry-cleaned stable after treatment of another
pig group with sulfadiazine powder for several days to
examine the effect of sulfonamide residues on plasma and
urine samples of these untreated animals.
Methods
Sulfadiazine formulations
For powder manufacturing, usual pig feed (powder,
Scharnebecker Muehle, Germany, comprising corn, wheat,
barley, peas, oat and sorghum) was supplemented with
sulfadiazine in the relevant concentrations (2.5 mg/kg body
weight (BW), 5 mg/kg BW and 25 mg/kg BW) during a
mixing process. Such sulfadiazine containing powder was
also used for producing pellets in a pelletising machine
under high pressure.
A granular formulation of sulfadiazine was produced
via fluidized-bed spray-granulation. Potato starch was
used as a binder in the granulation liquid consisting of
6 %(w/w) potato starch, 0.1 %(w/w) sulfadiazine and
93.9 %(w/w) deionized water. The granulation liquid was
boiled for starch gelation. 4000 g of pig feed were placed
in a fluidized-bed spray-granulator (WSG U5, Glatt
GmbH) and sprayed at a spray rate of 40 rpm. After
the spraying process, the granules were recovered and
dried to a humidity of 7 % before filling and further
application.
Animals
24 female piglets of a hybrid breed (db. Viktoria ×
db.77), all of which weighing 10–15 kg at the beginning
of the experiment, were obtained from the Lehr- und For-
schungsgut Ruthe, Germany. The pigs were kept under the
same conditions in groups of 6 animals and had free access
to tap water from drinking nipples. The pen measured
23.522, with 6 animals in bays of 8.82. A ventilation system
maintained a constant temperature of 19-20 ° C in the
stable, which was verified by random measurements.
All pigs were clinically healthy (determined via visual
examination) during the study. The study was approved
by the LAVES File number 33.12-42502-04-11/0338.
Experimental procedure
Pharmacokinetic studies were carried out in 4 groups of
6 pigs to determine the plasma and urine concentrations
of sulfadiazine as well as the environmental pollution.
Therefore, sulfadiazine was supplemented to the feed
(powder mixing, pelletisation, granulation), which was
given twice a day for four days. Events like feeding and
cleaning were standardized. Sulfadiazine contamination of
the stable was excluded before starting the experiment.
The whole experiment was performed in three differ-
ent parts:
The first group of 6 pigs was treated via powder feeding
(recommended formulation type) as follows: After 1 week
of acclimatisation, the pigs were weight and received sulfa-
diazine (Trimosulf®, WDT, Garbsen, Germany) in powder
in three different concentrations (two subtherapeutic con-
centrations) on 4 consecutive days. Between all treatments
a washout-phase of three days was inserted (determined
by a separate experiment). The first treatment was
2.5 mg/kg (subtherapeutic dosage) BW (body weight) for
4 days, followed by a washout-phase of three days. After-
wards, each pig received 5.0 mg/kg BW (subtherapeutic
dosage) sulfadiazine for 4 days, followed by three non-
medicated days. Finally, 25 mg/kg BW sulfadiazine (rec-
ommended dosage according to the package leaflet) was
orally administered to the pigs for four days. Afterwards,
the pigs were removed from the stable, which underwent
a dry cleaning process and 6 untreated piglets moved into
the stable in order to simulate a carry-over of sulfadiazine
of a polluted stable. These untreated pigs were kept in the
stable for 6 days and were fed with powder feed without
antibiotic supplementation.
The second and third group of pigs was treated with
sulfadiazine incorporated into pellets or granula in order
to determine formulations of sulfadiazine with a high bio-
compatibility and low environmental contamination. The
animals were treated with sulfadiazine (25 mg/kg BW) via
pellets or granula over 4 days each. The sulfadiazine con-
centration in the feed was as followed: 94 mg/kg (powder;
2.5 mg/kg BW), 151 mg/kg (powder; 5 mg/kg BW),
820 mg/kg (powder, pellets, granula; 25 mg/kg BW).
Chemicals
Sulfadiazine and sulfamerazine were purchased from
Sigma-Aldrich (Steinheim, Germany) and were of the
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highest purity available. Methanol (HPLC-grade) was
obtained from Applichem, Darmstadt, Germany.
Determination of plasma concentrations
Plasma samples were taken immediately before anti-
biotic medication and after 3 h. Therefore, blood was
collected from the jugular vein of each pig and was col-
lected in EDTA-containing plastic tubes. After centrifu-
gation for 10 min (3000 × g) the plasma was collected
and stored at −20 ° C until extraction procedure. Blood
of untreated pigs (sentinel pigs) was collected once a day
30 min after feeding.
Determination of urine concentrations Urine samples
were collected spontaneously once a day of each pig and
were stored at −20 ° C until analysis.
Collection of sedimentation dust
Sedimentation dust was collected at five different locali-
sations in the stable and was stored at–20 ° C until ex-
traction. Therefore, a card sheet was used to collect the
dust from a predefined surface area and the dust was
weight before extraction to determine the amount of
sulfadiazine in μg/mg dust. The localisations are shown
in Fig. 1.
The different areas are presented in Table 1, as well as
height of the sampling area and the distance to the feed-
ing area.
Aerosol collection
Air samples were taken simultaneously at two locations
in the animal house (Fig. 1). Therefore SKC pumps with
IOM samplers were used (PCWR (SKC INC., Eighty
Four, P.A. USA). The air flow of the pumps was adjusted
to 3 l/min. Dust was sampled on polycarbonate filters
(0.8 μm diameter of the pores; Whatman, Dassel, Germany)
over a time period of 9 h. The filters were weight before
and after usage to determine the amount of collected dust.
Extraction procedures
Sulfadiazine was extracted from plasma, urine, and stable
dust according to van Duijkeren (1994) [23]. Sulfamerazine
was used as internal standard for extraction procedure.
Analytical methodology
High performance liquid chromatography (HPLC) was
used to determine the amount of sulfadiazine and sulfa-
merazine consisting of the following parts (all Beckmann,
Muenchen, Germany) according to Zessel et al. 2013 [24].
A 508-autosampler was used to inject 100 μl of the sam-
ples into the HPLC-system and a 126 Solvent System
Pump maintained a constant flow of 1 ml/min. Separation
was achieved on a Rp-18 LiChroCart 250-4-column
(5 μm, 25 cm, Merck, Darmstadt, Germany) at 41 ° C.
Detection was performed at 264 nm by a UV–VIS-166-
Detector. The mobile phase consisted of 15 % methanol
Fig. 1 Scheme of the pig stable. The numbers indicate the 5 areas of sedimentation dust sample withdrawal (1. window sill, 2. grid above the
tub, 3. grid above the lying area, 4. gutters in front of the tub and 5. bay barrier on the other side of the stable), and “P” shows the positions of
air samplings. Bay 1 was used for all experimental setups
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and 85 % McIlvaine-citrate buffer (pH 2.2). The limit of
quantification (LOQ) was 0.1 μg/ml, the limit of detec-
tion was 0.09 μg/ml.
Statistics
Statistical analyses were carried out with the GraphPad
Prism program (version 6.05, GraphPad Software Inc.,
San Diego, CA, USA). A two way ANOVA was used to
gain information about significance, which was defined
as p < 0.05.
Results
Sulfadiazine treatment via powder resulted in dust con-
taminations at all localisations in the stable with the
highest amounts at the bay barrier in bay 2, followed by
the tub (up to 1.7 μg/mg dust), the windowsill, the lying
area, and the gutters in front of the tub (maximum
0.7 μg/mg dust, Table 2). Collected aerosol samples ex-
hibited up to 8 μg sulfadiazine per m3 air during powder
feeding of the recommended dosage (Table 3).
The ability of other oral dosage forms to diminish envir-
onmental contamination of sulfadiazine around treated
pigs in comparison to powder feeding was examined in
another experimental setup. Therefore, pellets and granula
were manufactured. Sedimentation dust samples and
aerosols (Tables 2 and 3) revealed amounts of sulfadia-
zine lower than the LOQ and maximum amounts of 0.1
to 0.2 μg/m3 air for both dosage forms. Even 10 % and
20 % of the recommended dosage given via powder
feed, resulted in sulfadiazine contamination of the stable,
that are sometimes even higher than dust samples col-
lected during treatment with the recommended dosage
given via pellets or granula.
Plasma and urine samples of all treated animals revealed
similar plasma and urine levels (maximum plasma levels
up to 14.2 μg/ml and urine levels up to 393 mg/ml, Figs. 2
and 3) of all dosage forms.
Untreated pigs (sentinel animals) were kept in the
stable after powder treatment of six other pigs for four
days. Analysis of the plasma demonstrates that only small
amounts of sulfadiazine are detectable in plasma (day 1
and 4 < LOQ) (Fig. 2), but with concentrations in the
urine up to 3.5 μg/ml on the first day of housing in the
stable (Fig. 4).
Discussion
One aim of the present study was to examine the amount
of environmental pollution of a commonly used oral dos-
age form (powder) of the test substance sulfadiazine in a
pig stable during a four-day treatment in comparison to
two other dosage forms. This general understanding is
necessary since examinations of Hamscher et al. (2003)
demonstrated that antibiotic residues (parent or metab-
olites) can be determined in stable dust during two de-
cades [22]. Therefore, sulfadiazine powder was added to
the powder feed, was mixed and was directly given to
the pigs in a tub. The results of the dust samples dem-
onstrate the importance of dust reduction in the stable
of antibacterially treated animals, since sulfadiazine treat-
ment via powder resulted in dust contaminations at all
localisations in the stable. The difference in the degree of
contamination in the different areas shows no satisfying
correlation to the distance to the feeding area but may be
explained by the air movement in the stable. Conse-
quently, air movement resulting from the air conditioning
has to be considered to reduce antibiotic contamination of
untreated animals, but also the animals itself may be the
reason for this differences, since trouble in the tub during
feeding may lead to swirl up small dust particles contain-
ing sulfadiazine [21, 25].
The ability of other oral dosage forms to diminish
environmental contamination of sulfadiazine around
treated pigs in comparison to powder feeding was ex-
amined in a second experimental setup. Therefore, pel-
lets and granula were manufactured. Sedimentation dust
samples and aerosols revealed amounts of sulfadiazine lower
than the LOQ (maximum amounts of 0.1 to 0.2 μg/m3 air)
for both dosage forms. Even 10 % and 20 % of the recom-
mended dosage given via powder feed, resulted in sulfadia-
zine contamination of the stable, that are sometimes even
higher than dust samples collected during treatment with
the recommended dosage given via pellets or granula.
Potential causes of this significantly lower sulfadiazine
concentration in the environment of pellet and granula
feeding in comparison to powder treatment have to be
considered. First of all, the origin of dust has to be eluci-
dated, since dust represents a mixture of particles deriving
from the litter, the animals (skin, hair, faeces), and the
food [21, 26]. The litter was the same in all experimen-
tal setups, so that this can be excluded as main reason
for dust reduction. The animals had all the same back-
ground, age and weight and were housed under the same
conditions, but since sulfadiazine is excreted mainly via
the urine, the excretion rates caused by differences in the
bioavailability of the different dosage forms had to be
investigated. Therefore, plasma and urine samples of all
Table 1 Locations of the sedimentation dust samples
withdrawal in the stable with distance to the tub and height of
sampling area
No. Location of the sampling
areas
Vertical distance to
the feeding tub (m)
Height of the
sampling area (m)
1 window sill 2 2.1
2 grid above the tub 0.0 1.4
3 grid above the lying area 2 1.4
4 gutters in front of the tub 0.6 0.0
5 bay barrier in bay 2 2.5 1.1
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Table 3 Amount of sulfadiazine per m3 air (aerosol) measured on 4 days during the experiment
Aerosol μg sulfadiazine per m3 air
Day 1 Day 2 Day 3 Day 4
Powder 2.5 mg/kg BW < LOQ < LOQ < LOQ < LOQ
5.0 mg/kg BW 0.1 < LOQ 0.3 0.4
25 mg/kg BW 2.7 8.0 5.7 3.2
Pellets 25 mg/kg BW < LOQ < LOQ* < LOQ 0.2
Granula 25 mg/kg BW < LOQ 0.2* 0.1 < LOQ
Sentinels untreated 1.6 1.2 0.3 0.4
BW body weight, LOQ limit of quantification; * = p < 0.05 (vs. powder)
Table 2 Amount of sulfadiazine in μg/mg sedimentation dust at 5 localizations on 4 days
Localization Treatment μg sulfadiazine per mg sedimentation dust
Day 1 Day 2 Day 3 Day 4
1: Distance to the tub 2 m, height 2.10 m Powder 2.5 mg/kg BW < LOQ < LOQ < LOQ < LOQ
5.0 mg/kg BW < LOQ < LOQ < LOQ < LOQ
25 mg/kg BW 0.8 1.2 1.1 1.3
Pellets 25 mg/kg BW < LOQ** < LOQ** < LOQ** < LOQ**
Granula 25 mg/kg BW < LOQ** < LOQ** < LOQ** < LOQ**
Sentinels untreated 1.3 1.9 1.0 1.1
2: Distance to the tub 0 m, height 1.40 m Powder 2.5 mg/kg BW < LOQ < LOQ < LOQ < LOQ
5.0 mg/kg BW < LOQ 0.3 0.2 0.4
25 mg/kg BW 0.6 1.3 1.8 1.7
Pellets 25 mg/kg BW < LOQ < LOQ < LOQ* < LOQ*
Granula 25 mg/kg BW < LOQ < LOQ < LOQ* < LOQ*
Sentinels untreated 1.3 1.3 1.3 1.4
3: Distance to the tub 2 m, height 1.40 m Powder 2.5 mg/kg BW < LOQ < LOQ < LOQ < LOQ
5.0 mg/kg BW < LOQ n.d. 0.1 0.1
25 mg/kg BW 0.2 0.5 0.7 0.8
Pellets 25 mg/kg BW < LOQ < LOQ < LOQ* < LOQ*
Granula 25 mg/kg BW < LOQ < LOQ < LOQ* < LOQ*
Sentinels untreated 0.8 0.7 0.6 0.6
4: Distance to the tub 0.6 m, height 0 m Powder 2.5 mg/kg BW n.d. < LOQ < LOQ n.d.
5.0 mg/kg BW 0.1 0.2 0.1 0.1
25 mg/kg BW 0.2 0.5 0.7 0.5
Pellets 25 mg/kg BW < LOQ < LOQ < LOQ* < LOQ
Granula 25 mg/kg BW < LOQ < LOQ < LOQ* < LOQ
Sentinels untreated 0.8 0.9 0.9 0.8
5: Distance to the tub 2.5 m, height 1.10 m Powder 2.5 mg/kg BW < LOQ < LOQ < LOQ < LOQ
5.0 mg/kg BW < LOQ < LOQ < LOQ 0.1
25 mg/kg BW 0.2 n.d. 0.9 2.8
Pellets 25 mg/kg BW < LOQ < LOQ < LOQ < LOQ
Granula 25 mg/kg BW < LOQ < LOQ < LOQ < LOQ
Sentinels untreated 0.9 1.1 1.0 1.0
BW body weight, LOQ limit of quantification; * = p < 0.05 (vs. pellets), ** = p < 0.01 (vs. pellets)
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treated animals were determined during the experiment
and revealed similar plasma and urine levels for all
dosage forms. Since all dosage forms exhibited nearly
the same bioavailability, it can be concluded that the
sulfadiazine distribution took place during the feeding
process in dependence to the dosage form.
The possibility to absorb antibiotic residues from the
environment was shown by Kietzmann et al. (1995) and
raised the question if the detected sulfadiazine concen-
tration in the environment during powder feeding is high
enough to affect untreated animals in the dry cleaned
stable. Therefore, untreated pigs (sentinel animals) were
kept in the stable after powder treatment of six other pigs
for four days. Analysis of the plasma demonstrates that
only small amounts of sulfadiazine are detectable in
plasma (day 1 and 4 < LOQ), but with concentrations in
the urine up to 3.5 μg/ml on the first day of housing in
the stable. This is not astonishing, since the stable was
only dry cleaned and in sedimentation dust and aerosol
samples exhibited sulfadiazine concentrations up to
1.9 μg/mg sedimentation dust and 1.6 μg/m3 air. To
get knowledge about the magnitude of absorption, the
comparison of the sentinel animals with the subthera-
peutic dosages treated animals demonstrates that urine
concentrations of the sentinel animals were 3–8 times
lower than the sulfadiazine concentration in urine of the
animals treated with 10 % of the recommended dosage.
The sentinel animals were exposed to a mean sedimenta-
tion dust concentration of 1.0 μg/mg (Table 2) and reached
blood concentrations just below the limit of quantification
(approximately 0.05-0.07 μg/ml, data not shown). To reach
such a low plasma concentration the animals (body weight
of 10–15 kg) had to orally adsorb 19–71 mg sedimentation
dust (assuming a total blood volume of 4-7 % of the BW,
[27] and 100 % oral bioavailability) from the environment.
Since the aerosol exhibited mean sulfadiazine concentra-
tions of 0.87 μg/m3 air (Table 3), a pig with a body weight
of 10–15 kg and a blood concentration of 0.05-0.07 mg/ml
Fig. 2 Plasma concentration of sulfadiazine (SDZ; mean) in six pigs after powder feeding of sulfadiazine in three dosages: 2.5 mg/kg BW (body
weight; grey box), 5 mg/kg BW (black box) and 25 mg/kg BW (black triangle) and after pellet (dark grey triangle) and granula (bright grey triangle)
feeding in a concentration of 25 mg/kg BW; feeding was performed twice daily (asterisks)
Fig. 3 Urine concentration of sulfadiazine (SDZ; mean ± standard deviation) in six pigs after powder feeding of sulfadiazine in three dosages
(2.5 mg/kg BW (body weight), 5 mg/kg BW and 25 mg/kg BW) and after pellet and granula feeding; feeding was performed twice daily on day 1–4
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had to absorb 20–73.5 μg sulfadiazine, which in turn is
inhaled via 23–84 m3 air. Assuming a lung ventilation
of 4–5.6 l/min. [28], with a bioavailability via the lungs
of 100 %, 128–704 h would be necessary to absorb this
amount of sulfadiazine via aerosol. Therefore, it can be
concluded that the oral uptake of dust sedimentation
from the stable represents the main source of absorp-
tion and may be slightly completed via the lungs.
Conclusion
The present study demonstrates the importance of the
pharmaceutical formulation on the entry of antibiotic resi-
dues into the environment of orally treated pigs. Pellets
and granula produced lower concentrations of environ-
mental contamination with sulfadiazine.
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